Loading clinical trials...
Loading clinical trials...
Remodulin (Treprostenil sodium) is synthetic prostacyclin analog available as a solution for administration in the intravenous route. It is approved for treatment of class I - pulmonary hypertension f...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Rambam Health Care Campus
NCT05746039 · Obesity, Interstitial Lung Disease, and more
NCT04634916 · Kidney Disease, End-Stage, End-stage Renal Disease, and more
NCT03854071 · Heart Failure, Pulmonary Hypertension, and more
NCT07073820 · Pulmonary Hypertension
NCT07477197 · Adult Congenital Heart Disease, Pulmonary Hypertension, and more
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions